In Brief:
After more than 50 years of clinical experience using systemic corticosteroids for severe, acute asthma, there remains considerable uncertainty as to the onset of action, dose–response characteristics, duration of treatment, and optimal route of administration. A review of the literature offers guidance but many questions remain.
